Loading organizations...
H&Q Healthcare Investors functions as a closed-end fund, providing long-term capital appreciation by investing in the healthcare industry. It funds public and private companies across biotechnology, medical devices, and pharmaceuticals. This strategy offers diversified exposure to innovation and growth throughout the global healthcare market.
Established on October 31, 1991, the fund was initially managed by Hambrecht & Quist Capital Management LLC. Its creation was driven by the insight into specialized healthcare investment potential. Management later transitioned to Tekla Capital Management, then to abrdn Inc., consistently maintaining its focused healthcare mandate.
H&Q Healthcare Investors serves investors seeking focused global healthcare sector exposure via a professionally managed fund. Its vision is to achieve sustained capital appreciation by supporting companies advancing healthcare innovation. The fund's strategy emphasizes continued investment in public equity markets worldwide, aligning with the healthcare landscape's ongoing evolution.
H&Q Healthcare Investors has 7 tracked investments across 5 companies. The latest tracked deal is $6.3M Series A Extension in Neurovance in April 2014.